Ophthalmic medical technology company Glaukos has signed a definitive agreement and plan of...
- Could digital therapy be the future of mental health treatment?
- The doctor will see you now: making the whole patient-GP relationship virtual
- Medtronic launches Accurian RF ablation system in US
- FDA clears Alphatec neuromonitoring system for spine surgery
- Biotronik gets US regulatory approval for Orsiro stent
RTR Urology offers innovative new therapy for bladder cancer
21st Century Oncology unit RTR Urology is offering a new treatment using ‘blue light cystoscopy’ technology for its patients.
Ultrasound to enable targeted drug delivery for brain diseases
Columbia Engineering researchers have devised an ultrasound-based technique to restore dopaminergic pathway in the brain of patients with Parkinson's disease.
Beta Bionics reports positive data from iLet Bionic Pancreas’ study
Beta Bionics has announced favourable outcomes from a home-use study of its iLet Bionic Pancreas System using pre-filled cartridges of Zealand Pharma’s dasiglucagon.
Researchers to trial stem cell heart patches for damage repair
Researchers from Imperial College London have devised an approach to grow heart patches made of up to 50 million human stem cells as part of a project funded by the British Heart Foundation (BHF).
Amplatzer Piccolo Occluder Device
Amplatzer Piccolo™ Occluder is one of the first trans-catheter treatments to be approved for the treatment of patent ductus arteriosus (PDA), a common congenital disorder that results in a life-threatening opening in the heart of premature infants and newborns.
TherOx DownStream System
TherOx's SuperSaturated Oxygen (SSO2) Therapy is delivered by its DownStream® system, which creates and delivers the patient's super-oxygenated blood to the targeted ischemic regions of the heart in patients with acute myocardial infarction (AMI).
Saluda reports positive data for Evoke system to treat chronic pain
Australian device manufacturer Saluda Medical has reported favourable outcomes from two clinical studies of its Evoke ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) system in patients suffering from chronic pain.
Novartis’ SMA gene therapy comes with a $2.125m price tag
Novartis’ push to make Zolgensma profitable could pave the way for other such therapies if patient access can be increased and insurers are able to find payment schemes that make sense.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Rolf Rihs has been working at assembly system manufacturer Mikron Automation for nearly 17 years. Over that time, he has…